CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

The US Department of Health and Human Services has planned to cancel $500 million in funding for mRNA vaccines, citing ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...

The US Department of Health and Human Services is to cancel contracts and pull funding for some vaccines that are being ...

The projects — 22 of them — are being led by some of the nation’s leading pharmaceutical companies like Pfizer and Moderna to ...

HHS announced that it will no longer fund internal department research for mRNA vaccines for upper respiratory viruses like flu and COVID-19.

US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has said he will cut $500 million in funding for mRNA ...

With a market cap of $10.7 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development of ...

The US Department of Health and Human Services (HHS) has announced it will wind down its mRNA vaccine development efforts under the Biomedical Advanced Research and Development Authority (BARDA), ...

The targeting of the vaccine technology once considered revolutionary follows intense criticism by conservatives and anti-vaccine activists.